Advertisement
Screener

EVOKE PHARMA, INC. Form DEF 14A: Definitive proxy statement

EVOKE PHARMA, INC. Form DEF 14A: Definitive proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-04-10: Form DEF 14A; Period of report 2025-05-21; Description DEF 14A; Document evok-20250409.htm.
  • 2024-04-10: Form DEF 14A; Period of report 2024-04-10; Description DEF 14A; Document evok-20240410.htm.
  • 2023-03-29: Form DEF 14A; Description DEF 14A; Document evok-20230329.htm.
  • 2022-03-15: Form DEF 14A; Period of report 2022-04-27; Description DEF 14A; Document evok-def14a_20220427.htm.
FiledFormPeriod of reportDescriptionDocument
2025-04-10DEF 14A2025-05-21DEF 14Aevok-20250409.htm
2024-04-10DEF 14A2024-04-10DEF 14Aevok-20240410.htm
2023-03-29DEF 14ADEF 14Aevok-20230329.htm
2022-03-15DEF 14A2022-04-27DEF 14Aevok-def14a_20220427.htm
2021-03-26DEF 14A2021-05-05DEF 14Aevok-def14a_20210505.htm
2020-04-14DEF 14A2020-05-27DEF 14Aevok-def14a_20200527.htm
2019-03-21DEF 14A2019-05-02DEF 14Aevok-def14a_20181231.htm
2018-03-16DEF 14A2018-04-26DEF 14A - 2017evok-def14a_20180426.htm
2017-03-22DEF 14A2017-05-03DEF 14Aevok-def14a_20170503.htm
2016-03-15DEF 14A2016-04-27DEF 14Aevok-def14a_20160427.htm
2015-03-09DEF 14A2015-04-22DEF 14Aevokdef14a.htm
2014-04-08DEF 14A2014-05-20DEF 14Ad684508ddef14a.htm